Novel DCB for Coronary Artery Disease Trial

Novel DCB for Coronary Artery Disease Trial - Novel DCB Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036420

Enrollment

220

Registered

2019-04-05

Start date

2019-04-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

Up to 3 pcs for 1 patient

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Male and female over 20 years old - Patients with CAD as class II of CCS - Patients with proven ischemia in coronary artery - Patients who can be treated with PCI or CABG

Exclusion criteria

Exclusion criteria: - Female during pregnancy - Patients with creatinine level over 2.0mg/dl - Patients with liver dysfunction - Patients under evaluation for other clinical trials

Design outcomes

Primary

Measure	Time frame
MACE 12 Months	—

Countries

Japan

Contacts

Public ContactYusuke Oishi

Zeon Medical Inc. Business Development Department

Y.Oishi@zeon.co.jp03-3216-1267

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026